scorecardresearchMorepen Laboratories Share Price Live NSE, BSE, Today - Morepen Laboratories

Morepen Laboratories

BSE: 500288 | NSE: MOREPENLAB | ISIN: INE083A01026 | SECTOR: Biotechnology & Drugs

37.25 0.79 (2.17%)

27 Sep 2023, 09:59 (IST)
  • Open

  • High

  • Low

  • Prev Close

  • P/E

  • Median P/E

  • P/B

  • Median P/B

  • Market Cap

  • Volume

  • Vol. (20 day Avg.)

  • PEG

  • Div.Yield

  • Bid

  • Ask


Company Description

  • Biotechnology & Drugs
  • BSE

  • NSE

  • ISIN


Morepen Laboratories Limited is a pharmaceutical company. The Company is engaged in the business of manufacturing, producing, developing, and marketing a range of active pharmaceutical ingredients (APIs), branded and generic formulations and also the home health products. Its APIs include Apixaban, Edoxaban, Sitagliptin, Linagliptin, Empagliflozin, Atorvastatin, Loratadine, Desloratadine, Montelukast Sodium, Atorvastatin Calcium, Fexofenadine, Sitagliptin Phosphate, Vildagliptin and Rivaroxaban, among others. Its finished formulations include Intebact Capsules, Intelicaps Lax, Rythmix Kid Drop, Rythmix Kid Syrup, Kompact Powder, Saltum and Acifix 3X Suspension among others. Its home health products include Dr. Morepen 49W Room Air Purifier with HEPA Filter, Dr. Morepen VP06 Breathe Free Vaporizer, Dr. Morepen CN06 Compressor Nebulizer and Dr. Morepen ST03 Dual Head Stethoscope, among others. Its subsidiaries include Dr. Morepen Limited, Morepen Devices Limited, and Total Care Limited.

Company Officers

  • Sushil Suri

    Executive Chairman of the Board, Managing Director
  • Ajay Sharma

    Chief Financial Officer
  • Vipul Srivatava

    Compliance Officer, Company Secretary
  • Sanjay Suri

    Whole-Time Director